Journals / Haydarpaşa Numune Medical Journal / 2021 / Cilt: 61 - Sayı: 4

Awareness of Relation Between Erectile Dysfunction and Cardiovascular Diseases Among the Urologist In Turkey

Pages
406–411
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion and Conclusion: It was found that age and professional experience were decisive in the overall approach and generally, the urologists had high level of awareness about the relation between ED and CVD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Erectile dysfunction (ED) is considered as a risk factor for cardiovascular diseases (CVD), which stands among the most important causes of death worldwide.
📊
Key Findings & Data:Methods: An online questionnaire consisting of 13 questions was sent by email to urology specialists and urology assistants registered to the Turkish Association of Urology (TAU) communication network.
💡
Conclusion & Impact:Discussion and Conclusion: It was found that age and professional experience were decisive in the overall approach and generally, the urologists had high level of awareness about the relation between ED and CVD.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Erectile dysfunction (ED) is considered as a risk factor for cardiovascular diseases (CVD), which stands among the most important causes of death worldwide. For this reason, the evaluation of ED with a multidisciplinary approach is crucial. This study aims to assess the awareness of urologists in Turkey about the relation between ED and CVD. Methods: An online questionnaire consisting of 13 questions was sent by email to urology specialists and urology assistants registered to the Turkish Association of Urology (TAU) communication network. The questionnaire consisted of the first six questions including personal questions about working conditions and work experience, and the last seven questions about the awareness of the relation between ED and CVD. Results: 154 people participated in the questionnaire sent to urologist via the communication network of the TAU. 59.8% of the participants stated that they always questioned the presence of CVD in patients presenting with ED complaints, and 11.7% always asked for a cardiology consultation. The rate of requesting a cardiology consultation in ED patients was similar (p>0.05) among the participants when grouped based on the professional title, their interest in andrology, institution they worked, and frequency of seeing ED patients. However, in the 40 years of age and under group the rate of requesting cardiology consultation was significantly higher compared to over 40 years of age group (p=0.01). Discussion and Conclusion: It was found that age and professional experience were decisive in the overall approach and generally, the urologists had high level of awareness about the relation between ED and CVD.

🔖

Cite This Article

GÖNÜLTAŞ, S., BAŞTUĞ, Y. (2022). Awareness of Relation Between Erectile Dysfunction and Cardiovascular Diseases Among the Urologist In Turkey. Haydarpaşa Numune Medical Journal, Cilt: 61 - Sayı: 4, 406–411. https://ajindex.com/articles/535884

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. NIH consensus statement on ımpotence. Int J Impot Res 1993;5:181–99
  2. Çayan S, Kendirci M, Yaman Ö, Aşçı R, Orhan I, Usta MF, et al. Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish society of andrology male sexual health study group. Turk J Urol 2017;43:122–9
  3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol 1994;151:54–61
  4. Miner M. Kim ED. Cardiovascular disease and male sexual dysfunction. Asian J Androl 2015;17:3–4
  5. Raheem OA, Su JJ, Wilson JR, Hsieh T. The association of erectile dysfunction and cardiovascular disease: A systematic critical review. Am J Mens Health 2017;11:552–63
  6. Shamloul R, Ghanem H. Erectile dysfunction. Lancet 2013;381:153–65
  7. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated Type 2 diabetic patients. Circulation 2004;110:22–6
  8. Chaudhary RK, Shamsi BH, Chen H, Tan T, Tang K, Xing J. Risk factors for erectile dysfunction in patients with cardiovascular disease. J Int Med Res 2016;44:718–27
  9. Akt Aktoz T, Aktoz M, Tatlı E, Kaplan M, Turan FN, Barutcu A, et al. Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease. Int Urol Nephrol 2010;42:873–9
  10. Visser M, Paulus WJ, Vermeulen MR, Richir MC, Davids M, Wisselink W, et al. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature. Eur J Heart Fail 2010;12:1274–81
  11. Baumhäkel M, Böhm M. Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract 2007;1:361–6
  12. Montorsi P, Ravagnani PM, Vlachopoulos C. Clinical significance of erectile dysfunction developing after acute coronary event: Exception to the rule or confirmation of the artery size hypothesis? Asian J Androl 2015;17:21–5
  13. Giuliano F, Jackson G, Montorsi F, Morales M, P Raillard P. Safety of sildenafil citrate: Review of 67 double-blind placebocontrolled trials and the postmarketing safety database. Int J Clin Pract 2010;64:240–55
  14. Corinaldesi C, Di Luigi L, Lenzi A, Crescioli C. Phosphodiesterase Type 5 inhibitors: Back and forward from cardiac indications. J Endocrinol Invest. 201